(Q45456530)

English

Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation

scientific article published in July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

electroporation

1 reference

based on heuristic

inferred from title

author name string

Jianjun Chen

1

1 reference

Europe PubMed Central

14 December 2017

Fang Fang

2

1 reference

Europe PubMed Central

14 December 2017

Xiangzhong Li

3

1 reference

Europe PubMed Central

14 December 2017

Haiyan Chang

4

1 reference

Europe PubMed Central

14 December 2017

Ze Chen

5

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

23

1 reference

Europe PubMed Central

14 December 2017

4322-4328

1 reference

Europe PubMed Central

14 December 2017

34

1 reference

Europe PubMed Central

14 December 2017

describes a project that uses

electroporation

1 reference

based on heuristic

inferred from title

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Influenza at Christ's Hospital: March, 1974.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Plasmid DNA expression systems for the purpose of immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Gene transfer into muscle by electroporation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Recombinant neuraminidase vaccine protects against lethal influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Evolution of the influenza virus neuraminidase gene during drift of the N2 subtype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protective cellular immunity against influenza virus induced by plasmid inoculation of newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.03.035

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45456530&oldid=2076964450"